Refine by
Drug Development Articles & Analysis: Older
662 news found
Protheragen, a dedicated preclinical research service provider specializing in rare diseases, announces its comprehensive diagnostic development services aimed at empowering researchers in the realm of rare disease research and drug development. ...
In medical applications, they’re used in cancer therapies and viral infection drugs. Alfa Chemistry makes this possible by providing pure and highly diverse nucleosides with modified versions used in the development of oligonucleotide therapeutics. ...
These APIs are mostly regulators of neurotransmitters such as dopamine and serotonin, which are central to mental stability. These range from conventional drugs such as chlorpromazine and haloperidol, to noveler ones such as aripiprazole. ...
CD Formulation’s commitment to innovation is evident in their comprehensive suite of services, meticulously designed to meet the unique needs of researchers focusing on drug development and delivery. One of the cornerstones of CD Formulation’s technological prowess lies in solvent casting. ...
During this promotional period, customers will benefit from CD Formulation’s experience in formulation development and drug analysis to get a better outcome in their research projects. The offer incorporates a wide range of services, including transdermal patch development, a major service where CD Formulation shines by providing custom ...
They are also critical components in antibody-drug conjugate (ADC) linkers, facilitating targeted drug delivery, and in PROTAC linkers, enabling the development of novel protein degradation therapies. ...
As an innovative ophthalmic disease research company with a wide range of services in basic research, drug development, and preclinical studies, Ace Therapeutics has expanded its portfolio to include gene therapy solutions designed specifically to accelerate glaucoma drug discovery and development. ...
Ace Therapeutics is proud to announce the launch of its cardiovascular disease model development services, aiming to empower researchers and pharmaceutical companies with advanced tools and models to accelerate the study of cardiovascular diseases and drug discovery. ...
Protheragen-ING has recently announced its ability to provide freeze-drying flash-release formulation development services to clients involved in drug discovery and development worldwide. ...
In the ever-evolving landscape of pharmaceutical research and development, the demand for innovative and efficient drug discovery methods is more pressing than ever. ...
In the rapidly evolving landscape of pharmaceutical innovations, CD Formulation emerges as a key player, offering customized drug conjugates services that cater to the rising demands for advanced drug development. Specializing in complex biologic formulations, Biologics & Biosimilars service team of CD Formulation is revolutionizing how ...
This may include periods of water scarcity, a failure of existing water treatment technology, increased demand or new drug development. The rental of a mobile unit provides a trouble-free water treatment solution with servicing, spare parts and consumables supplied by the provider. ...
Kelly Bugatti, BOC Sciences is set to host an informative webinar that will delve into the latest advancements in utilizing Peptide-Drug Conjugates (PDCs) for the targeted treatment of Pulmonary Fibrosi BOC Sciences has been organizing regular webinars in the fields of life sciences, drug discovery, and chemistry. ...
This versatility is crucial for meeting the unique challenges faced in drug development and ensuring optimal performance in therapeutic applications. ...
Idiopathic pulmonary fibrosis (IPF) is a devastating disease characterized by progressive scarring of the lungs, which severely impairs lung function over time. Developing effective treatments for IPF has been a challenge for the medical community, as the mechanisms driving this disease are complex and not fully understood. To accelerate drug discovery, ...
Watertown, MA — October 24, 2024 — Biopharma PEG is excited to announce its extensive offerings of polyethylene glycol (PEG) products, including monofunctional, homobifunctional, heterobifunctional, and multi-arm PEGs, tailored for PEGylation in biopharmaceutical applications. With over 40 PEGylated drugs approved globally, the role of PEGylation in ...
MOFs, or metal-organic frameworks, are crystalline structures comprised of metal ions linked by organic ligands, forming highly porous materials that hold great potential for drug delivery and other biomedical applications. CD Formulation specializes in the development of these frameworks, carefully optimizing their properties to facilitate the precise delivery ...
These compounds have been thoroughly studied for their medicinal properties, with up to 70,000 plant species screened for clinical uses. Despite the challenges in drug development, biobased pharmaceutical chemicals offer significant advantages, including better patient tolerance and acceptance. Pharmaceutical companies must leverage modern techniques to explore ...
The CEO of CD Formulation enthusiastically shared, “We understand the critical role high-quality resources play in pioneering research and development. Through this special promotion, we are committed to empowering researchers to achieve remarkable academic results as the new academic year kicks ...
Ace Therapeutics, a preclinical contract research organization (CRO) actively engaged in mental illness research, has announced the launch of its model development services, which aim to revolutionize psychiatric drug research and development. ...